GlassScriptPhysician profile
Howard B Hsu
NPI 1336376714
$9,790.41
in general payments reported to CMS, 2019-2025
46 companies · $1,599 in 2025
The $1,599 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $980 · 2020: $681 · 2021: $1,769 · 2022: $1,448 · 2023: $1,577 · 2024: $1,735 · 2025: $1,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,894 · Entertainment: $17.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,893.65 |
| Entertainment | $17.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,634.87 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,037.65 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $945.37 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $867.23 | 2019-2025 | |
| Novo Nordisk INC | $705.67 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $647.18 | 2020-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $557.18 | 2019-2025 | Evenity, Repatha, Otezla |
| Sanofi-Aventis U.S. LLC | $438.52 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $293.14 | 2019-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.80 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $232.79 | 2019-2022 | |
| Abbott Laboratories | $185.51 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $153.70 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Novartis Pharmaceuticals Corporation | $149.07 | 2019-2023 | |
| Exact Sciences Corporation | $143.66 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $117.45 | 2019-2022 | |
| Allergan, INC. | $105.21 | 2019-2020 | |
| Sanofi Pasteur INC. | $101.07 | 2019-2025 | |
| Astellas Pharma US INC | $95.53 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $91.46 | 2024-2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $73.55 | 2019-2021 | |
| Radius Health, INC. | $69.97 | 2021-2025 | Tymlos |
| Aimmune Therapeutics, INC. | $65.87 | 2024-2025 | Zenpep |
| Otsuka America Pharmaceutical, INC. | $65.45 | 2023-2025 | Rexulti |
| Eisai INC. | $63.69 | 2025 | |
| Nestle Healthcare Nutrition INC. | $61.58 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $60.98 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.73 | 2022-2023 | |
| Antares Pharma, INC. | $55.75 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $47.99 | 2022-2023 | Seglentis, Livalo |
| Inspire Medical Systems, INC. | $45.51 | 2024 | Inspire |
| Biohaven Pharmaceutical Holding Company LTD. | $41.85 | 2022 | |
| Axsome Therapeutics, INC. | $40.31 | 2023 | Auvelity |
| Esperion Therapeutics, INC. | $39.51 | 2024-2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $31.21 | 2024 | Onpattro |
| Dexcom, INC. | $28.66 | 2021-2024 | Dexcom G6 Transmitter |
| E.R. Squibb & Sons, L.L.C. | $27.36 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $24.27 | 2023 | Gvoke Hypopen |
| Edwards Lifesciences Corporation | $23.55 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Lundbeck LLC | $23.23 | 2024 | Rexulti |
| Verona Pharma, INC. | $19.15 | 2025 | Ohtuvayre |
| Globus Medical, INC. | $18.18 | 2025 | Senza |
| Optos, INC. | $17.72 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Nevro Corp. | $16.70 | 2022 | |
| Neuronetics, INC. | $10.20 | 2019 | |
| Itamar Medical INC | $5.38 | 2025 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.